Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons

Experimental Neurology

Volumn 203, Issue 2, 2007, Pages 406-414

  Gonzalez Deniselle, Maria Claudia ^a   Garay, Laura ^a   Gonzalez, Susana ^a   Saravia, Flavia ^a   Labombarda, Florencia ^a   Guennoun, Rachida ^b   Schumacher, Michael ^b   De Nicola, Alejandro F ^a,c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b Universite Paris Sud   (France)

^c Argentina   (Argentina)

Author keywords

Brain derived neurotrophic factor; Choline acetyltransferase; Neuroprotection; Progesterone; Wobbler mice

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE ACETYLTRANSFERASE; MESSENGER RNA; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BICEPS BRACHII MUSCLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMOSOME 11; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE MUTATION; HORMONE ACTION; IN SITU HYBRIDIZATION; MALE; MOTONEURON; MOUSE; MOUSE STRAIN; MUSCLE ATROPHY; NERVE CELL DEGENERATION; NEUROMUSCULAR FUNCTION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINAL CORD VENTRAL HORN;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLINE O-ACETYLTRANSFERASE; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU HYBRIDIZATION; MICE; MICE, NEUROLOGIC MUTANTS; MOTOR NEURONS; NERVE DEGENERATION; PROGESTERONE; RNA, MESSENGER; SPINAL CORD;

EID: 33846468711     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.08.019     Document Type: Article

References (70)

1. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., and Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389 (1997) 856-860
2. Beck T., Lindholm D., Castrén E., and Wree A. BDNF protects against ischemia cell damage in rat hippocampus. J. Cereb. Blood Flow Metab. 14 (1994) 689-692
3. Beck M., Flachenecker P., Magnus T., Giess R., Reiners K., Toyka R.V., and Naumann M. Automomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 6 (2005) 100-103
4. Bigini P., Bastone A., and Mennini T. Glutamate transporters in the spinal cord of the wobbler mouse. NeuroReport 12 (2001) 1815-1820
5. Blondet B., Barlovatz-Meimon G., Festoff B.W., Soria C., Soria J., Rieger F., and Hantai D. Plasminogen activator in the neuromuscular system of the wobbler mutant mouse. Brain Res. 580 (1992) 303-310
6. Boillée S., Peschanski M., and Junier M.-P. The Wobbler mouse: a neurodegeneration jigsaw puzzle. Mol. Neurobiol. 28 (2003) 65-106
7. Bradley W.G. A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 52 (1999) 1427
8. Burke R., and Rudomin P. Spinal neurons and synapses. Handbook of Physiology. Section 1: The nervous system. Cellular Biology of Neurons, part 2 vol. 1 (1977), American Physiol. Soc., Bethesda, Maryland
9. Chun H.S., Son J.J., and Son J.H. Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implications in Parkinson's disease. NeuroReport 11 (2000) 511-514
10. Cudkowicz M.E., and Brown R.H. Amyotrophic lateral sclerosis and related motor neuron diseases. In: Jameson J.L. (Ed). Principles of Molecular Medicine (1998), Humana Press, New Jersey 907-911
11. Curtis R., Tonra J.R., Stark J.L., Adryan K.M., Park J.S., Cliffer K.D., Lindsay R.M., and Distefano P.S. Neuronal injury increases retrograde axonal transport of the neurotrophins to spinal sensory neurons and motor neurons via multiple receptor mechanisms. Mol. Cell. Neurosci. 12 (1998) 105-118
12. De Nicola A.F. Steroid hormones and neuronal regeneration. Adv. Neurol. 59 (1993) 199-206
13. Ferrini M., Lima A., and De Nicola A.F. Estradiol abolishes autologous down-regulation of glucocorticoid receptors in brain. Life Sci. 57 (1995) 2403-2412
14. Fonnum .F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115 (1969) 465-472
15. Giehl K.M., Schutte A., Mestres P., and Yan Q. The survival-promoting effect of glial cell line-derived neurotrophic factor on axotomized corticospinal neurons in vivo is mediated by an endogenous brain-derived neurotrophic factor mechanism. J. Neurosci. 18 (1998) 7351-7360
16. Gonzalez Deniselle M.C., Lopez-Costa J.J., Saavedra J.P., Pietranera L., Gonzalez S.L., Garay L., Guennoun R., Schumacher M., and De Nicola A.F. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11 (2002) 457-468
17. Gonzalez Deniselle M.C., Lopez Costa J.J., Gonzalez S.L., Labombarda F., Garay L., Guennoun R., Schumacher M., and De Nicola A.F. Basis of progesterone protection in spinal cord neurodegeneration. J. Steroid Biochem. Mol. Biol. 83 (2002) 199-209
18. Gonzalez Deniselle M.C., Garay L., Lopez-Costa J.J., Gonzalez S., Mougel A., Guennoun R., Schumacher M., and De Nicola A.F. Progesterone treatment reduces NADPH-diaphorase/nitric oxide synthase in Wobbler mouse motoneuron disease. Brain Res. 1014 (2004) 71-79
19. Gonzalez Deniselle M.C., Garay L., Gonzalez S., Guennoun R., Schumacher M., and De Nicola A.F. Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease. Exp. Neurol. 195 (2005) 518-523
20. Gonzalez S.L., Labombarda F., Gonzalez Deniselle M.C., Guennoun R., Schumacher M., and De Nicola A.F. Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience. 125 (2004) 605-614
21. Gonzalez S.L., Labombarda F., Gonzalez Deniselle M.C., Mougel A., Guennoun R., Schumacher M., and De Nicola A.F. Progesterone neuroprotection in spinal cord trauma involves up-regulation of brain-derived neurotrophic factor in motoneurons. J. Steroid Biochem. Mol. Biol. 94 (2005) 143-149
22. Gulino R., Lombardo S.A., Casabona A., Leanza G., and Perciavalle V. Levels of brain-derived neurotrophic factor and neurotrophin-4 in lumbar motoneurons after low-thoracic spinal cord hemisection. Brain Res. 1013 (2004) 174-181
23. Hansson A.C., Sommer W.H., Metsis M., Stromberg I., Agnati L.F., and Fuxe K. Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter. J. Neuroendocrinol. 18 (2006) 104-114
24. Ikeda K., Kinoshita M., Iwasaki K., Tayaga N., and Shiojima T. Lecithinized superoxide dismutase retards wobbler mouse motoneuron disease. Neuromusc. Disord. 5 (1995) 383-393
25. Ikeda K., Iwasaki Y., Kinoshita M., Marubuchi S., and Ono S. T-588, a novel neuroprotective agent, delays progression of neuromuscular dysfunction in wobbler mouse motoneuron disease. Brain Res. 858 (2000) 84-91
26. Ikeda O., Murakami M., Ino H., Yamazaki M., Koda M., Nakayama C., and Moriya H. Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes up-regulation of myelin basic protein expression. J. Neuropathol. Exp. Neurol. 61 (2002) 142-153
27. Ishiyama T., Ogo H., Wong V., Klinkosz B., Noguchi H., Nakayama C., and Mitsumoto H. Methionine-free brain derived neurotrophic factor in wobbler mouse motor neuron disease: dose-related effects and comparison with the methionyl form. Brain res. 944 (2002) 195-199
28. Ishiyama T., Okada R., Nishibe H., Mitsumoto H., and Nakayama C. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease. Brain Res.1019 (2004) 226-236
29. Junier M.P., Legendre P., Esguerra C.V., Tinel M., Coulpier M., Dreyfus P.A., and Bahr M. Regulation of growth factor gene expression in degenerating motoneurons of the murine mutant wobbler: a cellular patch-sampling/RT-PCR study. Mol. Cell. Neurosci. 12 (1998) 168-177
30. Kato T. Choline acetyltransferase activities in single spinal motor neurons from patients with amyotrophic lateral sclerosis. J. Neurochem. 52 (1989) 636-640
31. Kishino A., Ishige Y., Tatsuno T., Nakayama C., and Noguchi H. BDNF prevents and reverses adult motor neuron degeneration and induces axonal outgrowth. Exp. Neurol. 144 (1997) 273-276
32. Koda M., Murakami M., Ino H., Yoshinaga K., Ikeda O., Hashimoto M., Yamazaki M., Nakayama C., and Moriya H. Brain-derived neurotrophic factor suppresses delayed apoptosis of oligodendrocytes after spinal cord injury in rats. J. Neurotrauma. 19 (2002) 777-785
33. Kobayashi N.R., Fan D.P., Ghiel K.M., Bedard A.M., Wiegand S.J., and Tetzlaff W. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha 1-tubulin mRNA expression, and promote axonal regeneration. J. Neurosci. 17 (1997) 9583-9595
34. Koliatsos V.E., Clatterbuck R.E., Winslow J.W., Cayouette M.H., and Price D.L. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron. 10 (1993) 359-376
35. Labombarda F., Guennoun R., Gonzalez S., Roig P., Lima A., Schumacher M., and De Nicola A.F. Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord. Neurosci. Lett. 288 (2000) 29-32
36. Labombarda F., Gonzalez S., Gonzalez Deniselle M.C., Guennoun R., Schumacher M., and De Nicola A.F. Cellular basis for progesterone neuroprotection in the injured spinal cord. J. Neurotrauma 19 (2002) 343-355
37. Labombarda F., Gonzalez S., Gonzalez Deniselle M.C., Vinson G.P., Schumacher M., De Nicola A.F., and Guennoun R. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25 Dx in the rat spinal cord. J. Neurochem. 87 (2003) 902-913
38. Labombarda F., Pianos A., Liere P., Eychenne B., Gonzalez S., Cambourg A., De Nicola A.F., Schumacher M., and Guennoun R. Injury elicited increase in spinal cord neurosteroid content analysed by gas chromatography mass spectrometry. Endocrinology 147 (2006) 1847-1859
39. Lindsay R.M., Wiegand S.J., Altar C.A., and DiStefano P.S. Neurotrophic factors: from molecule to man. Trends Neurosci. 17 (1994) 182-190
40. Liu Q.R., Lu L., Zhu X.G., Gong J.P., Shaham Y., and Uhl G.R. Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res. 1067 (2006) 1-12
41. Lou H., Kim S.K., Zaitsev E., Snell C.R., Lu B., and Loh Y.P. Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase e. Neuron. 45 (2005) 245-255
42. Lowry O.H., Rosebrough N.H., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
43. Magnaghi V., Cavarretta I., Galbiati M., Martini L., and Melcangi R.C. Neuroactive steroids and peripheral myelin proteins. Brain Res. Rev. 37 (2001) 360-371
44. Majewska M.D., Harrison N.L., Shwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
45. Mitsumoto H., and Bradley W.G. Murine motor neuron disease (the Wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain Res. 105 (1982) 811-834
46. Mitsumoto H., and Gambetti P. Impaired slow axonal transport in wobbler mouse motor neuron disease. Ann. Neurol. 19 (1986) 36-43
47. Mitsumoto H., Ikeda K., Klinkosz B., Cedarbaum J.M., Wong V., and Lindsay R.M. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265 (1994) 1052-1053
48. Mitsumoto H., Klinkosz B., Pioro E.P., Tsuzaka K., Ishiyama T., O'Leary R.M., and Pennica D. Effects of cardiotrophin-1 (CT-1) in a mouse motor neuron disease. Muscle Nerve. 24 (2001) 769-777
49. Nagappan G., and Lu B. Activity-dependent modulation of BDNF receptor TrkB: mechanisms and implications. Trends Neurosci. 28 (2005) 464-471
50. Nawa H., and Takei N. BDNF as an anterophin; a novel neurotrophic relationship between brain neurons. Trends Neurosci. 24 (2001) 683-684
51. Nitta A., Fukumitsu H., Kataoka H., Nomoto H., and Furukawa S. Administration of corticosterone alters intracellular localization of brain-derived neurotrophic factor-like immunoreactivity in the rat brain. Neurosci. Lett. 226 (1997) 115-118
52. Oda Y., Imai S., Nakanishi I., Ichikawa T., and Deguchi T. Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathol. Int. 45 (1995) 933-939
53. Pederson T. Growth factors in the nucleolus?. J. of Cell Biol. 143 (1998) 279-281
54. Pernas-Alonso R., Schaffner A.E., Perrone-Capano C., Orlando A., Morelli F., Hansen C.T., Barker J.L., Esposito B., Cacucci F., and di Porzio U. Early upregulation of medium neurofilament gene expression in developing spinal cord of the wobbler mouse mutant. Brain Res. Mol. Brain Res. 38 (1996) 267-275
55. Price D.L., Cleveland D.W., and Koliatsis V.E. Motor neuron disease and animal models. Neurobiol. Dis. 1 (1994) 3-11
56. Roof R., Hoffman S., and Stein D. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol. Chem. Neuropathol. 31 (1997) 1-11
57. Rupprecht R., Hauser C.A.E., Trapp T., and Holsboer F. Neurosteroids: molecular mechanisms of action and psychopharmacological significance. J. Setroid Biochem. Molec. Biol. 56 (1996) 163-168
58. Sagot Y., Rosse T., Vejsada R., Perrelet D., and Kato A.C. Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease. J. Neurosci. 18 (1998) 1132-1141
59. Sayer F.T., Oudega M., and Hagg T. Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord. Exp. Neurol. 175 (2002) 282-296
60. Schmitt-John T., Drepper C., Mubmann A., Hahn P., Kuhlmann M., Thiel C., Hafner M., Lengeling A., Heimann P., Jones J.M., Meisler M.H., and Jockusch H. Mutation of Vsp54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat. Genet. 37 (2005) 1213-1215
61. Schumacher M., Guennoun R., Robert F., Carelli C., Gago N., Ghoumari A., Gonzalez Deniselle M.C., Ibanez C., Labombarda F., Coirini H., Baulieu E.E., and De Nicola A.F. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm. and IGF Res. 14 (2004) S18-S33
62. Sohrajbi F., Miranda R.C., and Toran Allerand C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11110-11114
63. Thomas K., and Davies A. Neurotrophins: a ticket to ride for BDNF. Current Biol. 15 (2005) R262-R264
64. Tsuzaka K., Ishiyama T., Pioro E.K., and Mitsumoto H. Role of brain-derived neurotrophic factor in wobbler mouse motor neuron disease. Muscle Nerve 24 (2001) 474-480
65. Wang W., Salvaterra P.M., Loera S., and Chiu A.Y. Brain-derived neurotrophic factor spares choline acetyltransferase mRNA following axotomy of motor neurons in vivo. J. Neurosci. Res. 47 (1997) 134-143
66. Winkler T., Sharma H.S., Stalberg E., and Badgaiyan R.D. Neurotrophic factors attenuate alterations in spinal cord evoked potentials and edema formation following trauma to the rat spinal cord. Acta Neurochir., Suppl. 76 (2000) 291-296
67. Wong J.Y., Liberatore G.T., Donnan G.A., and Howells D.W. Expression of brain-derived neurotrophic factor and TrkB neurotrophin receptors after striatal injury in the mouse. Exp. Neurol. 148 (1997) 83-91
68. Yan Q., Matheson C., and Lopez O. The biological responses of axotomized adult motoneurones to brain-derived neurotrophic factor. J. Neurosci. 14 (1994) 5281-5291
69. Yung K.K., Tang F., and Vacca-Galloway L.L. Alterations in acetylcholinesterase and choline acetyltransferase activities and neuropeptide levels in the ventral spinal cord of the Wobbler mouse during inherited motoneuron disease. Brain Res. 638 (1994) 337-342
70. Zafra F., Castrén E., Thoenen H., and Lindholm D. Interplay between glutamate and γ-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc. Natl. Acad. Sci. 88 (1991) 10037-10041